Experimental Lilly combination drug tops Zepbound in weight-loss trial – Reuters By Weight Loss Haven Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial CNBC Lilly’s retatrutide GLP-1 delivers average weight loss of 50 pounds USA Today Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest